Skip to main content

Rainbow Childrens Medicare Ltd

NSE: RAINBOW BSE: 543524Healthcare

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

1,351
52W: ₹1009 — ₹1646
PE 55.9 · Book ₹156 · +766% vs book
Market Cap₹13,721 Cr
Stock P/E55.9Price to Earnings
ROCE18.3%Return on Capital
ROE16.7%Return on Equity
Div. Yield0.22%Face Value ₹10

Strengths

  • +Company's median sales growth is 24.3% of last 10 years
  • +Company's working capital requirements have reduced from 47.7 days to 19.5 days

Weaknesses

  • Stock is trading at 8.60 times its book value

Shareholding Pattern

Promoters49.84%
FIIs17.24%
DIIs21.12%
Public11.68%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters49.87%49.85%0.049.85%49.85%49.85%49.85%49.84%0.049.84%
FIIs24.78%25.12%0.325.12%23.69%1.423.6%0.121.85%1.819.24%2.617.24%2.0
DIIs13.81%13.84%0.013.87%0.015.31%1.415.44%0.117.46%2.019.49%2.021.12%1.6
Public11.53%11.2%0.311.16%0.011.14%0.011.11%0.010.82%0.311.4%0.611.68%0.3

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales319322326315404382354335408394
Expenses204208223225260251243235268264
Operating Profit11411410390143130111100141131
OPM %36%35%32%29%36%34%31%30%34%33%
Net Profit64615039776755527366
EPS ₹6.36.024.973.827.626.65.375.097.26.48

AI Insights

Revenue Trend

TTM revenue at ₹1,492Cr, up 2.5% YoY. OPM at 32%.

Debt Position

Borrowings at ₹727Cr. Debt-to-equity ratio: 0.49x. Healthy balance sheet.

Capex Cycle

CWIP at ₹52Cr (4% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 21.12% (+5.76pp change). FIIs: 17.24% (-2.96pp change). Promoters hold 49.84%.

Margin & Efficiency

ROCE improving from 0% (Mar 2015) to 18% (Mar 2025). Working capital days: 19.

Valuation

PE 55.9x with 18.3% ROCE. Price is 766% above book value of ₹156. Dividend yield: 0.22%.

Recent Announcements